Patent US5461065A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5461065A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for inhibiting endometriosis

Assignee: Eli Lilly and Co
•
Filing: 1993-10-15
•
Granted: 1995-10-24
•
Expires: 2013-10-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula <IMAGE> (I) Wherein R1 and R3 are independently hydrogen, -CH3, <IMAGE> wherein Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.

Inventors

  • 👤 Larry J. Black
  • 👤 George J. Cullinan
  • 👤 Michael W. Draper
  • 👤 Charles D. Jones
  • 👤 David E. Seyler

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 17:55
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/38; A61K31/381; A61K31/395; A61K31/40; A61K31/4025; A61K31/435; A61K31/44; A61K31/445; A61K31/4523; A61K31/4535; A61P; A61P13/00; A61P13/02; A61P15/00; A61P15/02; C; C07; C07D; C07D409/00; C07D409/02; C07D409/10

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 63 words
A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR5## Wherein R 1 and R 3 are independently hydrogen, --CH 3 , ##STR6## wherein Ar is optionally substituted phenyl; R 2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Claim 2
Independent Claim 63 words
A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR5## Wherein R 1 and R 3 are independently hydrogen, --CH 3 , ##STR6## wherein Ar is optionally substituted phenyl; R 2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Claim 3
Dependent Claim 13 words
The method of claim 1 wherein said compound is the hydrochloride salt thereof.
Claim 4
Dependent Claim 14 words
The method of claim 1 wherein said compound is ##STR7## or its hydrochloride salt.

References Cited (Backward Citations)

US4133814A Cited
US4380635A Cited
US4418068A Cited
US5075321A Cited
WO1993010113A1 Cited
WO1993010741A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-10-23 1999-04-24 1999-10-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-10-23 2003-04-24 2003-10-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-10-23 2007-04-24 2007-10-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag